Fungal keratitis is a serious corneal infection that can lead to vision impairment if not promptly diagnosed and treated. It is commonly caused by filamentous fungi such as Fusarium and Aspergillus, as well as yeasts like Candida. This condition often occurs following corneal trauma, contact lens use, or in individuals with compromised ocular surfaces. Symptoms include eye pain, redness, blurred vision, and photophobia. Diagnosis of fungal keratitis involves a detailed clinical examination, corneal scraping for microscopy and culture, and sometimes molecular diagnostic techniques. The corneal ulcers resulting from fungal infections can progress rapidly, leading to corneal melting and perforation. Treatment typically includes antifungal medications such as voriconazole, natamycin, or amphotericin B, either topically or systemically, depending on the severity and depth of the infection. In some cases, surgical intervention may be necessary to manage complications and prevent further damage. Prevention strategies for fungal keratitis include proper contact lens hygiene, avoiding trauma to the cornea, and addressing risk factors like ocular surface diseases. Timely and appropriate management is crucial to minimize the risk of visual impairment and long-term complications associated with fungal keratitis.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation